Twitter update Brief update: we have data pouring in from 3 different programs testing our @DermaPrecise with all kinds of injectables, materials, and specifications. This is helping us narrow down most ideal applications for market launch and FDA submissions. (1/2)
We are nearly finished preparations on an Early Adopter Program for Key Opinion Leaders in three continents for pre-clinical and clinical evaluations in different applications. @DermaPrecise #dermalinjector #dermalinjection More details announced shortly.(2/2)